| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lisinopril | FAERS: 38 | US FAERS | |
| 2 | benazepril | FAERS: 3 | US FAERS | |
| 3 | Enalapril | FAERS: 2 | US FAERS | |
| 4 | Capecitabine | FAERS: 1 | US FAERS | |
| 5 | Iopamidol | FAERS: 1 | US FAERS | |
| 6 | Perindopril | FAERS: 1 | US FAERS | |
| 7 | Sorafenib | FAERS: 1 | US FAERS | |
| 8 | Valsartan | FAERS: 1 | US FAERS | |
| 9 | ioversol | FAERS: 1 | US FAERS | |
| 10 | Bortezomib | OFFSIDES | ||
| 11 | Celiprolol | OFFSIDES | ||
| 12 | Isradipine | OFFSIDES | ||
| 13 | Nisoldipine | OFFSIDES | ||
| 14 | Ramipril | SIDER | ||
| 15 | Risperidone | SIDER | ||
| 16 | benazeprilat | SIDER | ||
| 17 | benazepril | SIDER | ||
| 18 | bismuth subsalicylate | OFFSIDES | ||
| 19 | trandolapril | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.